Related Experiment Video
Updated: Jul 14, 2026
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
Published on: August 24, 2015
[Factors affecting posttransfusion platelet efficiency "close relationship between patient and product"].
1Service recherche EFS Centre-Atlantique, 2 boulevard Tonnellé, BP 52009, 37020 Tours cedex 1, France. luc.sensebe@efs.sante.fr
Understanding factors influencing platelet transfusion outcomes is crucial for effective patient care. Optimizing platelet therapy requires considering patient conditions and product characteristics to prevent transfusion refractoriness.
Area of Science:
- Hematology
- Transfusion Medicine
Context:
- Platelet transfusion efficacy is influenced by numerous patient and product variables.
- Patient factors include physical characteristics (weight, height) and pathological conditions (splenomegaly, fever, infection, disseminated intravascular coagulation, HLA allo-immunization).
- Treatment-related factors, such as amphotericin use, can also impact outcomes.
Purpose:
- To identify and summarize key patient- and product-related factors affecting platelet transfusion success.
- To highlight critical elements influencing refractoriness and suboptimal responses to platelet therapy.
Summary:
- Impaired platelet transfusion responses are linked to decreased platelet dosage, ABO-incompatible products, and storage exceeding 48 hours.
- Addressing these factors is essential for preventing and managing transfusion refractoriness.
- Close collaboration between blood banks and clinical teams is vital for successful platelet transfusion management.
Impact:
- Improved patient outcomes through optimized platelet transfusion strategies.
- Reduced incidence of transfusion refractoriness and associated complications.
- Enhanced clinical decision-making in managing patients requiring platelet support.
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
12:40Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
Related Concept Videos
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
02:45Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:18Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:15Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...